Torrent Pharmaceuticals Limited — Updates, 28-07-2025: Press Release

Torrent Pharma reported strong Q1 FY26 results with consolidated revenue up 11% to Rs 3,178 Cr and net profit jumping 20% to Rs 548 Cr. Operational EBITDA grew 14% to Rs 1,032 Cr. The board approved issuing Non-Convertible Debentures via private placement. A significant business development is the planned acquisition of a controlling 46.39% stake in J.B. Chemicals & Pharmaceuticals for approximately Rs 11,917 Cr, followed by an open offer and future merger. India, Brazil, and US businesses showed robust growth, although Germany faced supply disruptions.